Rev Bras Ortop (Sao Paulo)
April 2023
The objective of this work is to compare blood loss during primary knee arthroplasty with the use of intravenous and intraarticular (IV + IA) tranexamic acid intraarticular (IA) tranexamic acid alone. This is a randomized, double-blind clinical trial. Patients with indication for primary total knee arthroplasty were recruited in a specialized clinic, where they were operated by the same surgeon, always using the same surgical technique.
View Article and Find Full Text PDF